Literature DB >> 25934694

Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.

Dane Cheasley1, Lloyd Pereira2, Shienny Sampurno2, Oliver Sieber3, Robert Jorissen3, Huiling Xu4, Markus Germann2, Yan Yuqian4, Robert G Ramsay5, Jordane Malaterre4.   

Abstract

UNLABELLED: Cyclin E1 is essential for the reentry of quiescent cells into the cell cycle. When hypomorphic mutant Myb mice (Myb(Plt4)) were examined, it was noted that Cyclin E1 (Ccne1) expression was reduced. Furthermore, the induction of Ccne1 in recovering intestinal epithelia following radiation-induced damage was ablated in Myb-mutant mice. These data prompted us to investigate whether Myb directly regulated Ccne1 and to examine whether elevated Myb in colorectal cancer is responsible for Cyclin E1-driven tumor growth. Here, it was found that Myb/MYB and Ccne1/CCNE1 expressions were coupled in both mouse and human adenomas. In addition, the low molecular weight Cyclin E1 was the predominant form in intestinal crypts and adenomatous polyposis coli (Apc)-mutant adenomas. Chromatin immunoprecipitation (ChIP) analysis confirmed that Myb bound directly to the Ccne1 promoter and regulated its endogenous expression. In contrast, Myb(Plt4) served as a dominant-negative factor that inhibited wild-type Myb and this was not apparently compensated for by the transcription factor E2F1 in intestinal epithelial cells. Myb(Plt4/Plt4) mice died prematurely on an Apc(Min/) (+) background associated with hematopoietic defects, including a myelodysplasia; nevertheless, Apc(Min/) (+) mice were protected from intestinal tumorigenesis when crossed to Myb(Plt4/) (+) mice. Knockdown of CCNE1 transcript in murine colorectal cancer cells stabilized chromosome ploidy and decreased tumor formation. These data suggest that Cyclin E1 expression is Myb dependent in normal and transformed intestinal epithelial cells, consistent with a cell-cycle progression and chromosome instability role in cancer. IMPLICATIONS: This study demonstrates that Myb regulates Cyclin E1 expression in normal gastrointestinal tract epithelial cells and is required during intestinal tumorigenesis. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25934694     DOI: 10.1158/1541-7786.MCR-15-0014

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

1.  Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model.

Authors:  Toan Pham; Sandra Carpinteri; Shienny Sampurno; Lloyd Pereira; Sara Roth; Vignesh Narasimhan; Phillip Darcy; Jayesh Desai; Alexander G Heriot; Robert G Ramsay
Journal:  J Gastrointest Surg       Date:  2019-01-08       Impact factor: 3.452

2.  Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.

Authors:  Shafquat Azim; Haseeb Zubair; Sanjeev K Srivastava; Arun Bhardwaj; Asif Zubair; Aamir Ahmad; Seema Singh; Moh'd Khushman; Ajay P Singh
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

Review 3.  MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.

Authors:  Ylenia Cicirò; Arturo Sala
Journal:  Oncogenesis       Date:  2021-02-26       Impact factor: 7.485

4.  Chromatin occupancy and target genes of the haematopoietic master transcription factor MYB.

Authors:  Roza B Lemma; Marit Ledsaak; Bettina M Fuglerud; Geir Kjetil Sandve; Ragnhild Eskeland; Odd S Gabrielsen
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

5.  Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases.

Authors:  Michela Pucci; Nadia Malagolini; Fabio Dall'Olio
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

6.  CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.

Authors:  Partha Mitra; Ren-Ming Yang; James Sutton; Robert G Ramsay; Thomas J Gonda
Journal:  Oncotarget       Date:  2016-02-23

7.  MYB is a novel regulator of pancreatic tumour growth and metastasis.

Authors:  Sanjeev K Srivastava; Arun Bhardwaj; Sumit Arora; Seema Singh; Shafquat Azim; Nikhil Tyagi; James E Carter; Bin Wang; Ajay P Singh
Journal:  Br J Cancer       Date:  2015-12-10       Impact factor: 7.640

8.  Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating β-catenin via a novel C-terminal domain.

Authors:  Yu-Ting Chou; Jeng-Kai Jiang; Muh-Hwa Yang; Jeng-Wei Lu; Hua-Kuo Lin; Horng-Dar Wang; Chiou-Hwa Yuh
Journal:  PLoS Biol       Date:  2018-01-16       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.